References
Jordan CT . Unique molecular and cellular features of acute myelogenous leukemia stem cells. Leukemia 2002; 16: 559–562.
Tse KF, Mukherjee G, Small D . Constitutive activation of FLT3 stimulates multiple intracellular signal transducers and results in transformation. Leukemia 2000; 14: 1766–1776.
Lee JT Jr, McCubrey JA . The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia. Leukemia 2002; 16: 486–507.
Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PR, Reese CB et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα. Curr Biol 1997; 7: 261–269.
Hsu J, Shi Y, Krajewski S, Renner S, Fisher M, Reed JC et al. The Akt kinase is activated in multiple myeloma tumor cells. Blood 2001; 98: 2853–2855.
Nicholson KM, Anderson NG . The protein kinase B/Akt signall-ing pathway in human malignancy. Cell Signal 2002; 14: 381–395.
Brognard J, Clark AS, Ni Y, Dennis PA . Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res 2001; 61: 3986–3997.
Nakatani K, Thompson DA, Barthel A, Sakaue H, Liu W, Weigel RJ et al. Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines. J Biol Chem 1999; 274: 21528–21532.
Acknowledgements
This study was supported by a grant of the Korea Health Ministry of Health & Welfare, Republic of Korea (02-PJ1-PG3-20802-0005).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Min, Y., Eom, J., Cheong, J. et al. Constitutive phosphorylation of Akt/PKB protein in acute myeloid leukemia: its significance as a prognostic variable. Leukemia 17, 995–997 (2003). https://doi.org/10.1038/sj.leu.2402874
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402874
- Springer Nature Limited
This article is cited by
-
Chidamide increases the sensitivity of refractory or relapsed acute myeloid leukemia cells to anthracyclines via regulation of the HDAC3 -AKT-P21-CDK2 signaling pathway
Journal of Experimental & Clinical Cancer Research (2020)
-
Targeting HDAC3, a new partner protein of AKT in the reversal of chemoresistance in acute myeloid leukemia via DNA damage response
Leukemia (2017)
-
Inhibition of serotonin receptor type 1 in acute myeloid leukemia impairs leukemia stem cell functionality: a promising novel therapeutic target
Leukemia (2017)
-
Rheb1 promotes tumor progression through mTORC1 in MLL-AF9-initiated murine acute myeloid leukemia
Journal of Hematology & Oncology (2016)
-
High constitutive Akt2 activity in U937 promonocytes: effective reduction of Akt2 phosphorylation by the histamine H2-receptor and the β2-adrenergic receptor
Naunyn-Schmiedeberg's Archives of Pharmacology (2016)